These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 25131561)
21. Chicken SLAMF4 (CD244, 2B4), a receptor expressed on thrombocytes, monocytes, NK cells, and subsets of αβ-, γδ- T cells and B cells binds to SLAMF2. Straub C; Neulen ML; Viertlboeck BC; Göbel TW Dev Comp Immunol; 2014 Feb; 42(2):159-68. PubMed ID: 24055739 [TBL] [Abstract][Full Text] [Related]
22. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study. Pongpruttipan T; Sukpanichnant S; Assanasen T; Wannakrairot P; Boonsakan P; Kanoksil W; Kayasut K; Mitarnun W; Khuhapinant A; Bunworasate U; Puavilai T; Bedavanija A; Garcia-Herrera A; Campo E; Cook JR; Choi J; Swerdlow SH Am J Surg Pathol; 2012 Apr; 36(4):481-99. PubMed ID: 22314189 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. Satoh M; Seki S; Hashimoto W; Ogasawara K; Kobayashi T; Kumagai K; Matsuno S; Takeda K J Immunol; 1996 Nov; 157(9):3886-92. PubMed ID: 8892619 [TBL] [Abstract][Full Text] [Related]
24. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate. Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685 [TBL] [Abstract][Full Text] [Related]
25. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria. D'Ombrain MC; Hansen DS; Simpson KM; Schofield L Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374 [TBL] [Abstract][Full Text] [Related]
27. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor. Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792 [TBL] [Abstract][Full Text] [Related]
28. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934 [TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733 [TBL] [Abstract][Full Text] [Related]
30. Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. Ebert LM; Meuter S; Moser B J Immunol; 2006 Apr; 176(7):4331-6. PubMed ID: 16547270 [TBL] [Abstract][Full Text] [Related]
31. Separation methods of T cells, natural killer, and dendritic cells from peripheral blood of cancer patients using interleukin-2 and functional analysis of natural killer cells after separation. Matsushita N; Aruga A; Kobayashi Y; Tanigawa K; Yamamoto M Immunopharmacol Immunotoxicol; 2007; 29(1):31-47. PubMed ID: 17464765 [TBL] [Abstract][Full Text] [Related]
33. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas. Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles. Seo N; Tokura Y J Interferon Cytokine Res; 1999 Jun; 19(6):555-61. PubMed ID: 10433355 [TBL] [Abstract][Full Text] [Related]
35. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells. von Lilienfeld-Toal M; Nattermann J; Feldmann G; Sievers E; Frank S; Strehl J; Schmidt-Wolf IG Clin Exp Immunol; 2006 Jun; 144(3):528-33. PubMed ID: 16734623 [TBL] [Abstract][Full Text] [Related]
36. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers. Kim EK; Ahn YO; Kim S; Kim TM; Keam B; Heo DS Cytotherapy; 2013 Feb; 15(2):231-241.e1. PubMed ID: 23321334 [TBL] [Abstract][Full Text] [Related]
37. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study. Uchiyama T; Sato N; Narita M; Yamahira A; Iwabuchi M; Furukawa T; Sone H; Takahashi M Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877 [TBL] [Abstract][Full Text] [Related]
38. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625 [TBL] [Abstract][Full Text] [Related]
39. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients. Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731 [TBL] [Abstract][Full Text] [Related]
40. Expansion of NK cells by engineered K562 cells co-expressing 4-1BBL and mMICA, combined with soluble IL-21. Jiang B; Wu X; Li XN; Yang X; Zhou Y; Yan H; Wei AH; Yan W Cell Immunol; 2014 Jul; 290(1):10-20. PubMed ID: 24859012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]